Zydus Lifesciences Ltd. on Tuesday said it has received approval from the U.S. health regulator to market an ointment to treat a skin disorder known as rosacea.
The company has received final approval from the U.S. Food and Drug Administration to manufacture and market Metronidazole Topical Cream, the drug maker said in a regulatory filing.
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder — rosacea, a type of adult acne.
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad, Zydus Lifesciences said.
As per IQVIA data, Metronidazole Topical Cream (0.75%) had annual sales of $25 million in the US.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
